| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |